Specifically, the proportion of patients with advanced T stage, clinical stage, and high histological grade increased from C1 to C2 and then to C3, reflecting an increasing trend in tumor malignancy, indicating that our molecular classification accurately captures and reflects the continuum of HCC clinical aggressiveness.
← all excerpts
Plasma exosomal lncRNA-related signatures define molecular subtypes and predict survival and treatment response in hepatocellular carcinoma.
1
—
—